A Single-dose, Dose-escalation Study of a Long-acting MOD-6031 in Healthy Overweight or Obese Subjects
Clinical trial NCT02692781 · COMPLETED
Trial details
- NCT number
- NCT02692781
- Sponsor
- OPKO Health, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-12-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.